Daniel G. Fuster

Associate Professor of Nephrology @inselgruppe and @unibern. Kidney stone and rare kidney disease enthusiast. Passion for skiing, climbing and alpinism.

[Andreas Kronbichler @AKronbichler]

It was a huge pleasure to work alongside a global team and contribute to the CKD series published in @TheLancet (article 1 out of 3).

https://t.co/2yYXOx2aC3

[Daniel G. Fuster @Dan_Fuster]

We need effective drugs to prevent stones !

[Daniel G. Fuster @Dan_Fuster]

Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention - The Lancet https://t.co/6qmiGKA9zM

Congratulations to the study team for the conduct of this trial. Longterm adherence to dietary recommendations remains a major challenge…..

[Tobias B. Huber @Tobias_B_Huber]

Obinutuzumab shows significant efficacy in active SLE.

[Andreas Kronbichler @AKronbichler]

Join this global initiative, CRESCENDO, which collects data on patients with crescentic lesions on their kidney biopsy. Reach out to one of the team members. 6 continents, over 100 centers have registered already!

https://t.co/Fluv6mbxC7

@AnnetteBruchfe1 and Vanja Ivkovic

[Roman-Ulrich Müller @MuellerRom]

🚀 STOP-PKD-News!

Das zweite Prüfzentrum in Mainz ist nun offiziell freigegeben. Weitere folgen (DE, NL, ES, AT).

Kann SGLT2-Inhibition das Fortschreiten von Zystennieren positiv beeinflussen?

Infos und Kontakte: https://t.co/6KKGuAQBXp

#STOPPKD #ADPKD
@PKD_Int

[Andreas Kronbichler @AKronbichler]

I am glad to work together with leading experts in the field of rare kidney diseases! Together these diseases are common! Thank you @GlomCon

[Vishal Patel @Vishal_D_Patel]

🧩 Many have wondered why the 1st-gen anti-miR-17 oligo RGLS4326 for #ADPKD didn’t advance, despite promising early clinical data.

💉At very high doses, it caused CNS toxicity in preclinical studies.

Our @NatureComms paper explains why
🔗 https://t.co/OBtjTRjL37

[Gunnar Henrik Heine @gunnar_heine]

IgA Nephropathy with two global leaders @MarkusAtHome:

An honor and pleasure to host
@IgAN_JBarratt @jradnephro

For our best of @NDTsocial webinar picked by @AKronbichler @hjanders_hans

https://t.co/HRPnkcKnHe via @YouTube

[Katalin Susztak @KSusztak]

@Tobias_B_Huber Thank you, dear Tobi — your friendship and leadership mean a great deal. No one advances alone; we are all part of a shared mission to understand and ultimately eliminate kidney disease. The future of nephrology is bright when science, collaboration, and vision come together.

[Andreas Kronbichler @AKronbichler]

Happy to see our review on "challenges" in ANCA-associated vasculitis published in @NatRevRheumatol! A special thanks to the Editorial Team and also @martacasalmoura for leading this initiative! #vasculitis @EUVAS19 @vasculitides

[Daniel Batlle @Dan_Batlle]

Congratulations Biff. Well deserved

[Jochen Reiser MD PhD @JochenReiser]

Congrats to ⁦@samirparikhmd⁩ and team⁩ for a breakthrough paper in ⁦@ScienceMagazine⁩ showing that somatically acquired heteroplasmic mtDNA mutations are a cause of chronic kidney disease and are functionally reversible.
⁦⁦@ASNKidney⁩ ⁦@the_asci⁩

👇👇

[Daniel G. Fuster @Dan_Fuster]

@AKronbichler @sara___helena @Tobias_B_Huber @MarcusSaemann Fantastic meeting. Congratulations Sara and Andreas - well done !!

[Andreas Kronbichler @AKronbichler]

The inaugural YNA meeting came to an end! @sara___helena must be commended for the visibility of #YNA!

[Sara Helena Ksiazek @sara___helena]

YNA Symposium Day 1 was a success🎉🫘☺️
@YNAnephro

[Andreas Kronbichler @AKronbichler]

Congratulations to @milena_bond and the Firenze Team!

[Andreas Kronbichler @AKronbichler]

An exceptional case we diagnosed 2 years ago with an extrarenal "crescent" formation (paravertebral mass). In the supplement you will see a selection of other rare manifestations including rupture of the A colica dextra. https://t.co/EZqYP4jXHQ

[Daniel G. Fuster @Dan_Fuster]

Just out in Nature Reviews Nephrology.
Kidney stone disease: risk factors, pathophysiology and management.
https://t.co/u8izdfaLjZ

[Daniel G. Fuster @Dan_Fuster]

Incredible work - congratulations Sarah and team !

JCI - Genetic variants predisposing to an increased risk of kidney stone disease https://t.co/OxdALT5fQA